Category

trading strategies

Trading Strategies

Make This Move by 4 p.m. Today ("Green Wednesday" Tomorrow)

Less than a day remains until Oct. 17.

The sun's going to rise on a different world tomorrow, one in which medical and – importantly – recreational marijuana will be freely available for purchase and use by consenting Canadian adults from the Yukon to Newfoundland.

Investors have even more to look forward to.

The latest analyst estimates (they're consistently being revised upward) could hardly be more bullish.

Research firm Deloitte expects – once you consider the growers, the value-added product makers, the testing labs, security, tourism, exports, and all the rest – the Canadian legal cannabis market soon could reach an eye-watering $22.6 billion.

And even at this late hour, there are still some must-own stocks that American investors can buy – easily, I'd add – to leverage this historic moneymaking opportunity.

Make sure you grab shares of these today...

Trading Strategies

Here Are Potential Market Trouble Spots I'm Watching Now

Right now in my paid research services, we almost always trade market extremes; the more extreme the move, the bigger the profits – like the 200% gain we made on VIAB the other day.

But the kinds of extremes we play depend in large part on the market's "narrative," the prevailing sentiments driving stock prices – up or down. That's why we align the bulk of our trades with that narrative.

At the moment, we're mostly looking at strong stocks, in quality companies, caught up in broader mechanical pullbacks. When the stock "snaps back" we see gains on the price and even bigger profits on trades we make on those shares. 

It sounds simple, and it's tough to argue with the profits. All this is happening because the market is telling us that it favors moves higher right now, and so a bullish overall stance is the right one to take.

But there are some troubling signs out there - some gray clouds out in the distance - that every investor needs to know about...

Trading Strategies

How to Make the Market Spill Its High-Profit Secrets

If you really think about it, the stock market closely resembles a living, breathing entity.

It's not a person, I mean, but more like an organism composed of millions and millions of cells.

It's each cell that's the person or institution making investment and trading decisions.

While individuals make buy and sell decisions, the pulse of the market and the general movement of the market, one way or another, is more often than not driven by the collective psychology of the organism.

If you understand the collective psychology that's moving the market, you can be exactly where you need to be almost all the time.

When you trade and invest based on the trend, you play stocks from the "long" side (the buy side) when the market's heading solidly, convincingly up.

And you play from the "short" side (short selling or put buying) when the market's trending down.

You'll find it's hard not to make money.

So here's what that giant, moving, thinking thing has on its mind...

Trading Strategies

The Great Canadian Cannabis Rally of 2018 Is Just Getting Started

The last month of action in Canadian cannabis stocks has many investors wondering:

"Have I missed the boat?"

Since Constellation Brands announced its blockbuster investment in Canopy Growth on Aug. 15, a bumper crop of additional good news has sent major Canadian cannabis stocks rocketing upward.

Cronos Group… 137%

Aurora Cannabis… 129%

Canopy Growth… 110%

Tilray… 613%

With gains like that, it's natural to ask if the boat has sailed, at least for the foreseeable future.

And in some cases, it's true that some of these companies have a lot of work to do to justify their new valuations. 

Fortunately, investors, even if they missed this rally, have incredible upside to look forward to in the cannabis sector...

Trading Strategies

What I Need to See from General Electric's New CEO

On my desk in my office here at Money Map Press is a yellowed newspaper clipping from mid-November 1997 – a Page 1A story featuring my byline.

I've kept this clipping for all these years because it was the last big "scoop" that I got for Gannett Newspapers in Rochester – right before I left for a job here in Baltimore.

I'd been covering the corporate flailing of the once-great Eastman Kodak for nearly five years – a journalistic vision quest that took me from Upstate New York to Silicon Valley, Hollywood, Japan, and even China.

The story that I broke that November was about a soon-to-be-announced corporate "restructuring" – a $1 billion, 10,000-layoff cost-cutting plan that Kodak was planning to share with Wall Streeters at a New York "event" the following Tuesday.

I didn't realize it at the time, but what I'd really written… was Kodak's epitaph.

The company's prospects had seemed much better four years earlier, after a huge shake-up at the top.

I still remember that brighter moment, when I was seated in the executive offices on the top floor of Kodak Tower in Rochester, N.Y.

Across the conference table from me was George M.C. Fisher, Kodak's just-appointed CEO and a vaunted "fix it" guy who was the first-ever outsider to lead the company.

I was there to interview Fisher. The topic on the table: the film giant's possible turnaround.

I was sitting in the room with a very shrewd executive, brought in from "outside" to right the ship...

Trading Strategies

Why These Two Pot Companies Keep Exchanging the "No. 1" Title

What an incredible time to own legal cannabis shares – particularly these shares.

Tilray and Aurora Cannabis have been the marijuana sector's "super stocks" of this summer. They've thrown off unthinkably large gains over the past few weeks and months.

Most recently, Tilray was riding high – up more than 30% – on news that it had secured U.S. Drug Enforcement Agency (DEA) approval to import research cannabis to the University of California San Diego's Center for Medicinal Cannabis Research.

And as you may have seen the other day, it's Aurora's turn for the spotlight...

Trading Strategies

The Shocking Ways "Big Government" Is Sending Cannabis Stocks Soaring

Summer 2018 was a season of surprises – mostly great ones – for cannabis investing.

Not long ago, few foresaw Corona's parent corporation Constellation Brands investing $3.8 million in what was already the world's biggest cannabis producer in its second deal together in less than a year…

Or Coca-Cola Co. starting negotiations with a cannabis company about a potential CBD-based beverage…

Or a British pharmaceutical developer getting the first U.S. Food & Drug Association approval for a cannabis-based medicine. 

Yet every one of those events happened… in short order.

With each time, cannabis stocks soared accordingly, especially for the companies directly involved.

Big news means major moves when it comes to cannabis investing.

But what I see as the biggest, most shocking developments of late haven't been happening in a board room. They've been happening in the shadows of the Capitol in Washington, D.C.

The U.S. cannabis policy thaw is already underway, and the ongoing developments associated with it are going to be game changers for investors who don't wait for too long on the sidelines.

These are first-time events that herald a brand-new era of cannabis profits for shareholders.

We're talking about real movement in the slow and steady end of the longtime federal prohibition of marijuana.

Here are the three things I'm watching closest...